Anastrozole (Animidex) 1mg

$32.00

Chemical Information and Compositions of Anastrozole (Animidex) 1mg

For researchers, biochemists, and wholesale distributors, the molecular structure of Anastrozole (Animidex) 1mg is a masterclass in targeted enzyme inhibition. Understanding its composition is vital for analytical testing, formulation, and predicting its biological behavior.

Official Chemical Nomenclature

  • Chemical Name: 2,3-bis[(4-cyanophenyl)methoxy]-2-methyl-2,3-dihydro-1H-1,2,4-triazole; α,α,α’,α’-tetramethyl-5-(1H-1,2,4-triazol-1-yl)-1,3-benzenediacetonitrile
  • Chemical Formula: C17H19N5
  • Molecular Weight: 293.37 g/mol
  • CAS Number: 120511-73-2

Structural Composition Breakdown

Anastrozole (Animidex) 1mg belongs to the benzyltriazole class of non-steroidal aromatase inhibitors. Its structural architecture is what gives it its phenomenal potency and absolute selectivity:

  1. The Triazole Ring: The core of the molecule features a 1,2,4-triazole ring. This ring is the functional “warhead” of the inhibitor. It interacts directly with the heme-iron atom (Fe) within the active site of the cytochrome P450 aromatase enzyme. The nitrogen atoms in the triazole ring coordinate with the iron, displacing the oxygen molecule that is required for the aromatization reaction, thereby shutting the enzyme down.
  2. The Bis-Benzyl Cyanile Moieties: The molecule features two symmetric benzonitrile (cyanophenyl) groups attached via methoxy bridges to the triazole ring. These bulky lipophilic groups are critical for binding affinity. They fit perfectly into the hydrophobic substrate-binding pocket of the aromatase enzyme, anchoring the triazole ring precisely over the heme-iron.
  3. Symmetry and Rigidity: The highly symmetric nature of Anastrozole contributes to its metabolic stability. Because it lacks the steroidal backbone of first- and second-generation AIs (like Exemestane/Formestane), it is not susceptible to breakdown by the same enzymatic pathways that metabolize steroids, giving it a highly predictable pharmacokinetic profile.

Physical and Chemical Properties

  • State at Room Temperature: Solid (Fine Crystalline Powder)
  • Color: White to off-white
  • Solubility: Practically insoluble in water (0.5 mg/mL). Moderately soluble in acetone, ethanol, and acetonitrile; freely soluble in organic solvents like DMSO, propylene glycol, and polyethylene glycol. Due to its poor aqueous solubility, it requires specific pharmaceutical excipients for oral bioavailability.
  • Melting Point: Approximately 81°C to 84°C.

Pharmacokinetics

  • Route of Administration: Oral
  • Absorption: Rapidly absorbed from the gastrointestinal tract. Food does not significantly alter the extent or rate of absorption, allowing it to be taken with or without meals.
  • Half-Life: The terminal elimination half-life of Anastrozole (Animidex) 1mg is approximately 40 to 50 hours (roughly 2 days). This long half-life allows for convenient once-daily dosing in clinical settings and stable plasma levels over the 24-hour period.’s
  • Metabolism: Anastrozole is extensively metabolized in the liver via N-dealkylation, hydroxylation, and glucuronidation. The major metabolite is triazole, which does not possess significant aromatase inhibitory activity.
  • (Crucial Note for Bodybuilders):* The enzyme Anastrozole inhibits (aromatase) upregulates (increases in number) in the presence of high androgen levels. Because the half-life of Anastrozole (Animidex) 1mg is ~50 hours, while the half-life of fast esters (like Testosterone Propionate) is much shorter, sudden drops in androgen levels post-injection can cause a temporary mismatch where estrogen production surges before the AI can fully adjust. This is why micro-dosing (EOD or E3D protocols) is often preferred over daily dosing in performance contexts.
  • Excretion: Approximately 10% of the dose is excreted in the urine as unchanged drug, with the remainder excreted as metabolites (roughly 60% in urine and 30% in feces).

Formulation Details: The 1mg Pill

When you source wholesale Anastrozole (Animidex) 1mg, you are dealing with a very low-dose, highly potent API. A 1mg pill contains exactly 1mg of Anastrozole base. Because 1mg is a microscopically small amount of active powder (roughly the size of a grain of salt), it must be geometrically diluted with excipients to create a handleable, uniform pill.

Standard excipients include:

  • Lactose Monohydrate: Used as a diluent/filler to add bulk to the tablet.
  • Microcrystalline Cellulose (MCC): A binder and filler that provides structural integrity and compressibility.
  • Croscarmellose Sodium: A super-disintegrant that ensures the pill breaks apart rapidly in the stomach to release the API.
  • Povidone (PVP): A binder that holds the powder granules together during compression.
  • Magnesium Stearate: A lubricant that prevents the powder from sticking to the tablet press punches and dies.

For B2B buyers, the uniform blending of 1mg of Anastrozole within 100-200mg of these excipients is the single greatest manufacturing challenge. Failure to achieve perfect geometric dilution results in “hot spots” (pills with 3mg) and “dead spots” (pills with 0mg), which are disastrous for endocrine management.